Cell Therapies in the Middle East: Where Do We Stand?

June 15-16, 2022 | 9-11 a.m. (CT)

Watch Day 1     Watch Day 2

Chairs: Ali Bazarbachi, MD, PhD, Jayandharan Rao, PhD, and Kenneth Cornetta, MD 


(View the event in your time zone)

June 15: CAR T Overview and Background 

9-9:10 a.m: Introduction 
Kenneth Cornetta, MD, Indiana University 

9:10-9:35 a.m.: CAR T Cells for Multiple Myeloma 
Rafat Abonour, MD, Indiana University 

9:35-10 a.m.: CAR T Cells for Lymphoma 
Mohamed Kharfan-Dabaja, MD, Mayo Clinic 

10-10:25 a.m. Management of CAR T Side Effects 
Ibrahim Yakoub-Agha, MD, PhD, Lille University Hospital 

10:25-10:55 a.m.: Panel Discussion 
Moderated by Kenneth Cornetta, MD, Indiana University, and Mohamad Mohty, MD, PhD, Saint-Antoine Hospital 

10:55-11 a.m.: Closing Remarks  
Mohamad Mohty¸ MD, PhD, Saint-Antoine Hospital 

June 16: State of Cell Therapy Development in the Field 

9-9:10 a.m.: Introduction 
Jayandharan Rao, PhD, IIT Kanpur 

9:10-9:35 a.m.: Progress with Advanced Cellular and Gene Therapy in Saudi Arabia 
Mahmoud Aljurf, MD, King Faisal Specialist Hospital & Research Center

9:35-10 a.m.: Academic CAR T Cell Program: From Research to Approval 
Álvaro Urbano-Ispizua, MD, Hospital Clínico de Barcelona 

10-10:25 a.m.: The Supply Chain for Autologous CAR-T Cells and Other IECs
Christian Chabannon, MD, PhD, Institut Paoli-Calmettes Comprehensive Cancer Center & Aix-Marseille Université School of Medicine

10:25-10:55 a.m.: Panel Discussion 
Moderated by Jayandharan Rao, PhD, IIT Kanpur and Ali Bazarbachi, MD, PhD, American University of Beirut 

10:55-11 a.m.: Closing Remarks  
Ali Bazarbachi, MD, PhD, American University of Beirut 


Register for the ASGCT Policy Summit

September 23-24, 2024 | Washington, D.C.

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.